Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Psychosis Associated With Alzheimer's Disease”

20 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 20 results

Large-scale testing (Phase 3)Study completedNCT00036114
What this trial is testing

Study of Aripiprazole in the Treatment of Patients With Psychosis Associated With Dementia of the Alzheimer's Type

Who this might be right for
Alzheimer Disease
Otsuka Pharmaceutical Development & Commercialization, Inc.
Large-scale testing (Phase 3)Study completedNCT03325556
What this trial is testing

Relapse Prevention Study of Pimavanserin in Dementia-related Psychosis

Who this might be right for
Dementia-related Psychosis
ACADIA Pharmaceuticals Inc. 392
Early research (Phase 1)Not Yet RecruitingNCT06388551
What this trial is testing

A Phase 1, SAD Study to Evaluate the Safety and Tolerability of LY03017

Who this might be right for
Hallucinations and Delusions Associated With Alzheimer's Disease PsychosisHallucinations and Delusions Associated With Parkinson Disease PsychosisNegative Symptoms of Schizophrenia
Luye Pharma Group Ltd. 60
Testing effectiveness (Phase 2)Looking for participantsNCT07459660
What this trial is testing

An Open-Label Study of ML-007C-MA in Adults With Alzheimer's Disease Psychosis

Who this might be right for
Psychosis Associated With Alzheimer's Disease
MapLight Therapeutics 210
Large-scale testing (Phase 3)Looking for participantsNCT06585787
What this trial is testing

Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)

Who this might be right for
Alzheimer Disease
Karuna Therapeutics, Inc., a Bristol Myers Squibb company 406
Early research (Phase 1)Not Yet RecruitingNCT06644573
What this trial is testing

Evaluating the Efficacy and Safety of PROSOMNIA Sleep Therapy™ in Patients With Sleep Deprivation and Chronic Insomnia

Who this might be right for
Chronic InsomniaSleep DeprivationREM Behavior Disorder+34 more
Nyree Penn 100
Large-scale testing (Phase 3)Study completedNCT01862640
What this trial is testing

A Phase 3, 12-week, Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Efficacy, Safety, and Tolerability of 2 Fixed Doses of Brexpiprazole in the Treatment of Alzheimer's Agitation

Who this might be right for
Agitation Associated WithAlzheimer's DiseaseAlzheimer's Type+2 more
Otsuka Pharmaceutical Development & Commercialization, Inc. 433
Large-scale testing (Phase 3)Ended earlyNCT00160147
What this trial is testing

Treatment of Elderly Subjects With Psychosis and Behavioral Disturbances Associated With Dementia of the Alzheimer's Type

Who this might be right for
Psychosis and Behavioral Disturbances Associated With Dementia of the Alzheimer's Type
Solvay Pharmaceuticals 60
Not applicableStudy completedNCT02192554
What this trial is testing

Safety Follow-up Study for Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Previously Participated in a Double-blind Trial of Brexpiprazole or Placebo

Who this might be right for
Agitation Associated With Alzheimer's DiseaseAlzheimer's TypeMental Disorder+1 more
Otsuka Pharmaceutical Development & Commercialization, Inc. 450
Large-scale testing (Phase 3)Looking for participantsNCT05511363
What this trial is testing

Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease (ADEPT-1)

Who this might be right for
Psychosis Associated With Alzheimer's Disease
Karuna Therapeutics, Inc., a Bristol Myers Squibb company 410
Large-scale testing (Phase 3)Ended earlyNCT00287742
What this trial is testing

The Effectiveness and Safety of Risperidone Versus Placebo in the Treatment of Patients With Hallucinations and Delusions Associated With Alzheimer's Disease

Who this might be right for
Alzheimer's DiseaseDementia
Janssen Pharmaceutical K.K. 33
Large-scale testing (Phase 3)Study completedNCT01438060
What this trial is testing

Aripiprazole in the Treatment of Patients With Psychosis Associated With Dementia of Alzheimer's Type

Who this might be right for
Dementia, Alzheimer Type
Otsuka Pharmaceutical Development & Commercialization, Inc. 232
Large-scale testing (Phase 3)Not Yet RecruitingNCT06947941
What this trial is testing

Evaluate Safety and Efficacy of KarXT + KarX-EC as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-5)

Who this might be right for
Alzheimer DiseasePsychosis
Bristol-Myers Squibb 1,046
Testing effectiveness (Phase 2)Looking for participantsNCT06887192
What this trial is testing

Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis

Who this might be right for
Psychosis Associated With Alzheimer's Disease
MapLight Therapeutics 300
Large-scale testing (Phase 3)Looking for participantsNCT05980949
What this trial is testing

Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associated With Alzheimer's Disease (ADEPT-3)

Who this might be right for
Psychosis Associated With Alzheimer's Disease
Karuna Therapeutics, Inc., a Bristol Myers Squibb company 800
Large-scale testing (Phase 3)Study completedNCT01922258
What this trial is testing

Safety and Tolerability Study of Flexible Dosing of Brexpiprazole in the Treatment of Subjects With Agitation Associated With Dementia of the Alzheimer's Type

Who this might be right for
Agitation Associated WithAlzheimer's DiseaseAlzheimer's Type+2 more
Otsuka Pharmaceutical Development & Commercialization, Inc. 270
Large-scale testing (Phase 3)Study completedNCT00041678
What this trial is testing

Study of Aripiprazole in the Treatment of Patients With Psychosis Associated With Dementia of the Alzheimer's Type

Who this might be right for
Alzheimer Disease
Otsuka Pharmaceutical Development & Commercialization, Inc.
Early research (Phase 1)Not Yet RecruitingNCT06980207
What this trial is testing

A Phase 1, MAD Study to Evaluate the Safety, Tolerability and Pharmacokinetics of LY03017

Who this might be right for
Hallucinations and Delusions Associated With Alzheimer's Disease PsychosisHallucinations and Delusions Associated With Parkinson Disease PsychosisNegative Symptoms of Schizophrenia
Luye Pharma Group Ltd. 40
Testing effectiveness (Phase 2)Looking for participantsNCT06540833
What this trial is testing

Assess the Efficacy and Safety of ITI-1284 in the Treatment of Psychosis Associated With Alzheimer's Disease

Who this might be right for
Psychosis Associated With Alzheimer's Disease
Intra-Cellular Therapies, Inc. 370
Large-scale testing (Phase 3)Active Not RecruitingNCT06126224
What this trial is testing

Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease (ADEPT-2)

Who this might be right for
Psychosis Associated With Alzheimer's Disease
Karuna Therapeutics, Inc., a Bristol Myers Squibb company 500